{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiaq32xj3i5i2x7r2sj6witcwe73k7j6hstfj4aodhqybnjutfk4mi",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mmzeb7alnz42"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidaqptmhoii4jd2w2bgwe7tpcalmqjqtgwadplnzshspzfjlm7pxq"
    },
    "mimeType": "image/jpeg",
    "size": 284746
  },
  "path": "/news/2026-05-rna-therapy-genetic-heart-failure.html",
  "publishedAt": "2026-05-29T15:00:02.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Using patient-derived cardiac tissue and stem cell-based models, the team of translational researchers demonstrated that targeting the genetic cause of disease improved cellular abnormalities and identified the biological pathways involved. The results of this study were published in Signal Transduction and Targeted Therapy.",
  "title": "RNA therapy for genetic heart failure moves closer to patients after lab gains"
}